UMGCC Paul Calabresi Clinical Oncology Training Program

UMGCC Paul Calabresi 临床肿瘤学培训计划

• 批准号: 7683191
• 负责人: EDWARD A. SAUSVILLE
• 金额: $ 70.81万
• 依托单位: UNIVERSITY OF MARYLAND BALTIMORE
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-09-05 至 2013-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7683191
• 关键词: Advisory Committees; Antineoplastic Agents; Applications Grants; Appointment; Area; Award; Baltimore; Bioinformatics; Biometry; Cancer Center; Clinical; Clinical Drug Development; Clinical Oncology; Clinical Protocols; Clinical Research; Clinical Trials; Combined Modality Therapy; Commit; Committee Members; Critiques; Data; Dental Assistants; Development; Doctor of Medicine; Doctor of Philosophy; Educational Curriculum; Environment; Faculty; Figs - dietary; Funding; Goals; K-Series Research Career Programs; Laws; Lead; Learning; Maryland; Master of Science; Master' s Degree; Medical; Mentors; Mentorship; NCI Scholars Program; Peer Review; Pharmacy facility; Population; Population Sciences; Postdoctoral Fellow; Public Health Schools; Radiation; Recruitment Activity; Reporting; Research; Research Activity; Research Project Grants; Research Support; Resource Sharing; Resources; SECTM1 gene; Schools; Science; Scientist; Seasons; Secure; Source; Surgical Oncology; Training; Training Programs; Translational Research; Treatment-Related Cancer; Underrepresented Minority; Underserved Population; Universities; anticancer research; base; cancer therapy; career; career development; design; drug discovery; experience; instrument; interest; medical schools; meetings; multidisciplinary; multimodality; population based; pre-clinical; professor; programs; success; treatment strategy

DESCRIPTION (provided by applicant): The University of Maryland Marlene and Stewart Greenebaum Cancer Center (UMGCC) Paul Calabresi Clinical Oncology Training Program will support career development and training of Calabresi Scholars in clinical oncology translational research. UMGCC Calabresi Scholars will have an M.D., D.O., or equivalent clinical degree, have finished clinical training, and be ready for a junior faculty appointment. In addition, Ph.D.s, Pharm.D.s, or R.N.s with a Ph.D. who have finished at least one post-doctoral experience and who are committing to a career in clinical oncology translational research are eligible. The themes to be promoted in the UMGCC Scholars Program reflect areas of UMGCC strength: multimodality treatment strategies for cancer; drug discovery and development; and clinical cancer research in underserved minority populations. The Program will provide a didactic learning experience leading to a Master of Science in Clinical Research; a clinical research experience that will focus each Scholar's development of a cancer therapy - related clinical trial to answer a hypothesis-based clinical research question with translational endpoints; and a basic/population science activity which will tie to the clinical protocol translational question. The Scholars will be assisted in these goals by each Scholar having a Mentorship Committee consisting of a Clinical Mentor, a Basic/Population Science Mentor, and a Biostatistical Mentor. In addition, an independent Grant Application Development Committee will be formed for each Scholar, unrelated to the Scholar's Mentor Committee, to promote success of the Scholar in securing independent, peer reviewed funding. The UMGCC Program is distinguished by a number of features including 1) participation and support from six professional Schools at the University of Maryland, Baltimore (UMB Schools of Medicine, Pharmacy, Nursing, Dental, Law and the newly formed UMB School of Public Health); 2) experienced, well-funded multidisciplinary mentors; 3) the strength of UMs existing K30 Clinical Research Curriculum for the Calabresi Scholars' didactic training; 4) close coordination and the sharing of resources with existing K12s, particularly the UM Multidisciplinary Clinical Research Career Development Award; 5) a clinical research base consisting of >150 open and accruing clinical trials reflecting multidisciplinary clinical expertise and Institutional commitment to support clinical research.

描述（由申请人提供）：马里兰大学Marlene and Stewart Greenebaum癌症中心（UMGCC） Paul Calabresi临床肿瘤学培训计划将支持Calabresi学者在临床肿瘤学转化研究方面的职业发展和培训。UMGCC Calabresi学者将拥有医学博士、医学博士或同等临床学位，已完成临床培训，并准备好担任初级教员。此外，博士学位，药学博士学位。具有博士学位、至少完成一项博士后研究并致力于临床肿瘤学转化研究的注册护士符合条件。联合海湾合作委员会学者计划将促进的主题反映了联合海湾合作委员会的优势领域：癌症的多模式治疗战略；药物发现和开发;以及在服务不足的少数群体中进行临床癌症研究。该计划将提供一个教学学习经验，导致科学的临床研究硕士学位；临床研究经验，将重点放在每个学者的癌症治疗相关临床试验的发展，以回答一个基于假设的临床研究问题与翻译终点；基础/人口科学活动将与临床方案转化问题联系起来。每位学者将有一个由临床导师、基础/人口科学导师和生物统计学导师组成的指导委员会来协助实现这些目标。此外，将为每位学者成立一个独立的资助申请发展委员会，与学者的导师委员会无关，以促进学者成功获得独立的、同行评审的资助。马里兰大学巴尔的摩分校医学院、药学院、护理学院、牙科学院、法学院和新成立的马里兰大学巴尔的摩分校公共卫生学院参与和支持马里兰大学巴尔的摩分校的六个专业学院；2)经验丰富、资金充足的多学科导师；3) UMs现有的K30临床研究课程对Calabresi学者的教学培训的优势；4)与现有的K12s，特别是澳大多学科临床研究职业发展奖密切协调和资源共享；5)临床研究基地，包括150个开放和累积的临床试验，反映多学科临床专业知识和机构对支持临床研究的承诺。